NASDAQ:DRTS

Alpha Tau Medical Stock Insider Trading

Healthcare > Biotechnology

Buy DRTS

*Your capital is at risk

$11.79

-0.100 (-0.84%)

At Close: Jul 31, 2026

Alpha Tau Medical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 16.08. In total, the insiders bought 6.19M and sold 112.27K DRTS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	16.08
● Buy	6.19M shares
● Sell	112.27K shares
90% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence Jun 30, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 18, 2026 Buy	Options	Sofer Uzi Chief Executive Officer	CEO / President	396 680 Value: $2.90M
Mar 18, 2026 Buy	Ordinary Shares	Adler Alan Director	Director	0 Value: $0
Mar 18, 2026 Buy	Restricted Share Units	Adler Alan Director	Director	0 Value: $0
Mar 18, 2026 Buy	Options	Adler Alan Director	Director	15 527 Value: $99.5K
Mar 18, 2026 Buy	Ordinary Shares	Blumenfeld S Morry Director	Director	0 Value: $0
Mar 18, 2026 Buy	Restricted Share Units	Blumenfeld S Morry Director	Director	0 Value: $0
Mar 18, 2026 Buy	Options	Blumenfeld S Morry Director	Director	15 527 Value: $99.5K
Mar 18, 2026 Buy	Ordinary Shares	Milch David Mark Director	Director	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Milch David Mark Director	Director	0 Value: $0
Mar 18, 2026 Buy	Restricted Share Units	Milch David Mark Director	Director	0 Value: $0
Mar 18, 2026 Buy	Options	Milch David Mark Director	Director	15 527 Value: $99.5K
Mar 18, 2026 Buy	Warrants	Milch David Mark Director	Director	49 000 Value: $563.5K
Mar 18, 2026 Buy	Ordinary Shares	Alon Ruth Director	Director	0 Value: $0
Mar 18, 2026 Buy	Restricted Share Units	Alon Ruth Director	Director	0 Value: $0
Mar 18, 2026 Buy	Options	Alon Ruth Director	Director	15 527 Value: $99.5K
Mar 18, 2026 Buy	Restricted Share Units	Netser Maya Director	Director	0 Value: $0
Mar 18, 2026 Buy	Restricted Share Units	Netser Maya Director	Director	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Netser Maya Director	Director	0 Value: $0
Mar 18, 2026 Buy	Options	Netser Maya Director	Director	15 527 Value: $99.5K
Mar 18, 2026 Buy	Ordinary Shares	Levy Raphi Chief Financial Officer	C-Suite Officer	0 Value: $0
Mar 18, 2026 Buy	Restricted Share Units	Levy Raphi Chief Financial Officer	C-Suite Officer	0 Value: $0
Mar 18, 2026 Buy	Restricted Share Units	Levy Raphi Chief Financial Officer	C-Suite Officer	0 Value: $0
Mar 18, 2026 Buy	Restricted Share Units	Levy Raphi Chief Financial Officer	C-Suite Officer	0 Value: $0
Jun 17, 2025 Buy	Options	Avruch Michael Director	Director	24 460 Value: $99.1K
Jun 17, 2025 Buy	Options	Sofer Uzi Chief Executive Officer	CEO / President	24 460 Value: $99.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ALPHA TAU MEDICAL LTD.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and othe...

Read Full Profile Here